Changchun BCHT Biotechnology Co. A (688276): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 14,93 Renminbi Yuan | 24,47 Renminbi Yuan | 13,3 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 32 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 413.657.598 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | 591.809,6 | 1.229.084,097 | 1.824.688,776 | 1.071.446,025 | 1.202.026,554 | 1.441.358,098 | 975.667,801 | 1.018.915,69 | 690.617,406 |
Cashflow aus operativer Geschäftstätigkeit | 231.207,058 | 406.502,236 | 255.206,956 | 39.818,408 | 140.301,565 | 209.164,566 | 232.795,993 | 269.794,087 | 177.052,589 |
▸ Operative Cashflow Marge | 39,07% | 33,07% | 13,99% | 3,72% | 11,67% | 14,51% | 23,86% | 26,48% | 25,64% |
Investitionsausgaben (CapEx) | 406.486,505 | 542.425,184 | 470.662,382 | 290.731,943 | 632.879,752 | 335.748,594 | 128.394,095 | 181.151,592 | 92.441,739 |
Cashflow aus Investitionstätigkeit | - | -541.483,899 | -638.626,382 | -288.715,809 | -695.509,164 | -333.591,451 | -128.394,095 | -154.764,496 | -101.869,55 |
Cashflow aus Finanzierungstätigkeit | - | 36.966,311 | -42.141,996 | -41.284,07 | 1.402.355,068 | 174.390,821 | -56.690,795 | -38.468,909 | -6.392,5 |
Freier Cashflow | -175.279,447 | -135.922,948 | -215.455,426 | -250.913,535 | -492.578,187 | -126.584,028 | 104.401,898 | 88.642,495 | 84.610,85 |
▸ Freie Cashflow Marge | -29,62% | -11,06% | -11,81% | -23,42% | -40,98% | -8,78% | 10,7% | 8,7% | 12,25% |
Ausgeschüttete Dividenden | -75.031,892 | -64.393,671 | -62.614,014 | -41.284,07 | -328,773 | -4.049,742 | -8.299,592 | -18.468,909 | -2.392,5 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.